31JUL

Arrakis: Blossom's second lead in 3 days

1 min read

12:32UTC

Arrakis, a London AI company, raised £22.5m on 24 July led by Blossom Capital, three days after the same fund led a twenty-one-year-old propulsion firm.

← Back to Humanoid hit $1.35bn on a customer order Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Arrakis closed £22.5m without a public product, which at Series A scale is now unremarkable.

Arrakis, a London artificial-intelligence (AI) company, raised a £22.5 million Series A on Friday 24 July led by Blossom Capital, with the venture funds Accel, GFC, MainObject and Rerail following ¹.

That is Blossom's second Series A lead in three days. On the Tuesday it led a Bedford propulsion company with patents, aircraft customers and twenty-one years of trading behind it. On the Friday it led an AI company at seed-plus scale. One fund, two leads, opposite ends of the evidence spectrum.

The weekly roundup labels Arrakis an AI company and names no product or market, and we could not reach a company release ². That absence is itself ordinary now. AI companies took a record share of UK smaller-business equity value last year , and at Series A scale a round can close on a founding team and a thesis before anything ships. We report the cheque and the syndicate, and leave the rest until somebody publishes it.

Deep Analysis

In plain English

Arrakis is a London company working on artificial intelligence software. It raised £22.5m from investors including Accel and GFC, with Blossom Capital leading the round. This was Blossom's second time leading a funding round in just three days, having also led Bedford company Greenjets' £30m raise days earlier, showing the same investment fund actively writing large cheques into very different kinds of British technology companies in the same week.

Deep Analysis

Root Causes

A single fund leading two Series A rounds three days apart reflects how venture partnerships allocate capital, not a hot sector. Partners at a fund like Blossom Capital run independent deal pipelines.

Two unrelated leads landing in the same week reflects diary timing and due-diligence completion dates rather than a coordinated thesis linking Greenjets' electric propulsion to Arrakis' AI software.

What could happen next?

Meaning
Blossom Capital's back-to-back leads signal an active deployment pace at the fund rather than a thematic bet spanning propulsion hardware and AI software.

Sources:UKTN

Mentions:Arrakis →BOKA Capital →Accel →GFC →MainObject →Rerail →London →Greenjets →

First Reported In

Update #13 · Humanoid hit $1.35bn on a customer order

UKTN· 31 Jul 2026

Read original →

Causes and effects

Caused by

Greenjets raises £30m in its 21st year

Blossom Capital's lead in Arrakis followed its Greenjets lead three days earlier, the same fund backing opposite ends of the evidence spectrum.

Occurred 21 Jul 2026

Read story →

This Event

Arrakis: Blossom's second lead in 3 days

One fund led two Series A rounds in the same week at opposite ends of the evidence spectrum, and the AI company's product remains unnamed in public.

Different Perspectives

Fubon Financial

Fubon Financial joined Humanoid's Series A on 21 July as a minority financial investor alongside Schaeffler and Bosch, who also hold the customer and manufacturer roles. A pure-play investor from Taipei is pricing a London robot maker on terms two German industrial groups effectively set.

NATO Innovation Fund

The Fund joined Greenjets' £30m Series A on 21 July alongside NSSIF, betting on ducted electric propulsion's civil market to fund a technology with an obvious defence application. It is backing a company that took twenty-one years to reach this stage, on the expectation that certification-cycle timelines reward patient capital over a quick return.

Prime Movers Lab

Prime Movers Lab led Humanoid's Series A on 21 July as the round's only pure financial investor, sharing the cap table with two co-investors who are also the anchor customer and the factory. That leaves the fund's usual arm's-length pricing role diluted by partners with a direct commercial stake in the valuation holding up.

Bosch and Schaeffler

Schaeffler signed what Humanoid calls the industry's largest publicly announced commercial agreement, while Bosch took equity and became contract manufacturer, filling capacity a shrinking combustion supply chain freed. Neither company has disclosed a unit count or an invoice, so their public commitment stops well short of Forbes' 100,000-unit projection.

UK founders raising seed through Series A

A London robotics founder raised $152m this week against a signed industrial customer and a reserved factory, while a Cornwall founder more typically draws a £25,000 loan from a regional fund manager. Both call it British venture funding, but one route runs through Bosch's production line and the other through diligence built for businesses too small for any VC's attention.

EQT

EQT was reported on 3 July to be in advanced talks for a further CuspAI stake on behalf of the EU's Scaleup Europe Fund, but does not appear on the round CuspAI closed. Whether Europe's own sovereign vehicle secured a position, was outbid, or withdrew is unresolved.